Advances in percutaneous balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension
10.3969/j.issn.1008-794X.2025.03.019
- VernacularTitle:经皮球囊肺动脉成形术在治疗慢性血栓栓塞性肺动脉高压中的进展
- Author:
Zhihui LU
1
;
Chen ZHANG
;
Xiaohai MA
Author Information
1. 100029 北京 首都医科大学附属北京安贞医院介入诊疗科
- Keywords:
percutaneous balloon pulmonary angioplasty;
chronic thromboembolic pulmonary hypertension;
interventional therapy
- From:
Journal of Interventional Radiology
2025;34(3):324-328
- CountryChina
- Language:Chinese
-
Abstract:
Chronic thromboembolic pulmonary hypertension(CTEPH)is a potentially life-threatening pulmonary vascular disease,which belongs to the fourth largest category of pulmonary hypertension as defined in the 2022 European Society of Cardiology guidelines.Percutaneous balloon pulmonary angioplasty(BPA)is an interventional technique,which uses continuous and phased balloon expansion to treat the narrowed site under pulmonary angiography guidance,providing a completely new therapeutic method for CTEPH patients who are unable to receive surgical treatment and for CTEPH patients who have post-surgical residual pulmonary hypertension.This paper comprehensively introduces the interventional therapeutic technology of BPA,focusing on the development history,the clinical indications and the development of operative technique of BPA,meanwhile,the latest development of BPA in the treatment of CTEPH is also introduced.
